EVOLENT HEALTH, INC.

(EVH)
  Report
Delayed Nyse  -  04:00 2022-08-16 pm EDT
33.11 USD   -2.93%
08/16INSIDER SELL : Evolent Health
MT
08/12EVOLENT HEALTH : Unregistered Sales of Equity Securities - Form 8-K
PU
08/12EVOLENT HEALTH, INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/10/2022 08/11/2022 08/12/2022 08/15/2022 08/16/2022 Date
35.68(c) 35.86(c) 34.93(c) 34.11(c) 33.11(c) Last
975 501 1 122 421 1 899 215 1 851 451 2 540 045 Volume
+1.51% +0.50% -2.59% -2.35% -2.93% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 346 M - -
Net income 2022 -21,5 M - -
Net Debt 2022 273 M - -
P/E ratio 2022 -146x
Yield 2022 -
Sales 2023 1 700 M - -
Net income 2023 7,11 M - -
Net Debt 2023 253 M - -
P/E ratio 2023 276x
Yield 2023 -
Capitalization 3 035 M 3 035 M -
EV / Sales 2022 2,46x
EV / Sales 2023 1,93x
Nbr of Employees 3 500
Free-Float 89,8%
More Financials
Company
Evolent Health, Inc. is a health care company that delivers clinical and administrative solutions to payers and providers. The Company supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The Company operates through two segments: Evolent Health Services and Clinical Solutions. Its Evolent Health... 
More about the company
Ratings of Evolent Health, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about EVOLENT HEALTH, INC.
08/16INSIDER SELL : Evolent Health
MT
08/12EVOLENT HEALTH : Unregistered Sales of Equity Securities - Form 8-K
PU
08/12EVOLENT HEALTH, INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
08/10Evolent Health to Participate in the CG Growth Conference
PR
08/03EVOLENT HEALTH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/03EVOLENT HEALTH, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
08/03RBC Raises Price Target on Evolent Health to $44 From $40, Maintains Outperform Rating
MT
08/03BTIG Adjusts Evolent Health's Price Target to $50 From $45, Reiterates Buy Rating
MT
08/03Piper Sandler Adjusts Evolent Health's Price Target to $40 From $35, Reiterates Overwei..
MT
08/02EVOLENT HEALTH : Q2 Earnings Snapshot
AQ
08/02TRANSCRIPT : Evolent Health, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02EVOLENT HEALTH, INC. : Entry into a Material Definitive Agreement, Results of Operations a..
AQ
08/02Evolent Health, Inc. Promotes Aammaad Shams to the Chief Accounting Officer and Control..
CI
08/02Earnings Flash (EVH) EVOLENT HEALTH Reports Q2 EPS $0.10
MT
08/02Earnings Flash (EVH) EVOLENT HEALTH Reports Q2 Revenue $319.9M
MT
More news
News in other languages on EVOLENT HEALTH, INC.
08/16VENTE D'INITIÉS : Evolent Health
08/02Evolent Health, Inc. promeut Aammaad Shams au poste de chef comptable et contrôleur de ..
08/02Earnings Flash (EVH) EVOLENT HEALTH annonce un chiffre d'affaires de 319,9 millions de ..
08/02Evolent Health, Inc. fournit des prévisions de résultats pour le troisième trimestre se..
08/02Evolent Health, Inc. annonce ses résultats pour le deuxième trimestre et le semestre cl..
More news
Analyst Recommendations on EVOLENT HEALTH, INC.
More recommendations
Chart EVOLENT HEALTH, INC.
Duration : Period :
Evolent Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOLENT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 33,11 $
Average target price 47,17 $
Spread / Average Target 42,5%
EPS Revisions
Managers and Directors
Seth B. Blackley Chief Executive Officer & Non-Independent Director
John Johnson Chief Financial Officer
Frank J. Williams Non-Executive Chairman
Frank Williams Co-Founder, Chairman
Steven Tutewohl Chief Actuary
Sector and Competitors
1st jan.Capi. (M$)
EVOLENT HEALTH, INC.19.66%3 035